NCT00855764 Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00855166 Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00852397 A Study to Evaluate the Safety of Apixaban in Acute Coronary Syndrome (ACS) Japanese Patients Status TERMINATED Phase PHASE2
NCT00851045 Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00850577 Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00847782 An Experimental Medicine Study to Evaluate Serum Biomarkers of Lipid Metabolism Status COMPLETED Phase NA
NCT00842556 Pharmacokinetic Drug Interaction Study of Dapagliflozin and Glimepiride or Sitagliptin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00839683 Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00838890 A Study of BMS-863233 in Patients With Hematologic Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00836602 Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00833703 Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation Status COMPLETED Phase PHASE3
NCT00833482 Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants Status COMPLETED Phase PHASE1
NCT00829647 A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia Status WITHDRAWN Phase PHASE1/PHASE2
NCT00828646 Safety Study of Multiple-dose of Gamma-secretase Inhibitor in Healthy Male Japanese and Healthy Elderly Japanese Status COMPLETED Phase PHASE1
NCT00827411 Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy Status COMPLETED Phase PHASE4
NCT00826449 Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE1/PHASE2
NCT00825955 Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment Status COMPLETED Phase PHASE3
NCT00825929 Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women. Status RECRUITING Phase N/A